AR019262A1 - Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso. - Google Patents

Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso.

Info

Publication number
AR019262A1
AR019262A1 ARP990101561A ARP990101561A AR019262A1 AR 019262 A1 AR019262 A1 AR 019262A1 AR P990101561 A ARP990101561 A AR P990101561A AR P990101561 A ARP990101561 A AR P990101561A AR 019262 A1 AR019262 A1 AR 019262A1
Authority
AR
Argentina
Prior art keywords
preparation
carrier
active substance
formulation
active substances
Prior art date
Application number
ARP990101561A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR019262A1 publication Critical patent/AR019262A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nozzles (AREA)

Abstract

Proceso para la preparacion de una sustancia activa o sustancias activas asociadas con un portador en el cual: se prepara una emulsion mezclando un líquidode fase no acuosa y un líquido de fase acuosa comprende la sustancia activa o sustancias activas y el portador está presente en al menos una de las fases;la emulsion se hace contactar con un gas fluido usando una técnica anti-solvente, se obtienen unidades liberadas de la fase líquida; y una formulacionpreparada como se describe en el procesoanterior.
ARP990101561A 1998-04-14 1999-04-06 Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso. AR019262A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Publications (1)

Publication Number Publication Date
AR019262A1 true AR019262A1 (es) 2002-02-13

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101561A AR019262A1 (es) 1998-04-14 1999-04-06 Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso.

Country Status (31)

Country Link
US (1) US6372260B1 (es)
EP (1) EP1069890B1 (es)
JP (1) JP2002511400A (es)
KR (1) KR100600691B1 (es)
CN (1) CN1201728C (es)
AR (1) AR019262A1 (es)
AT (1) ATE329580T1 (es)
AU (1) AU744874B2 (es)
BR (1) BR9909636A (es)
CA (1) CA2327522C (es)
CY (1) CY1105154T1 (es)
CZ (1) CZ20003784A3 (es)
DE (1) DE69931904T2 (es)
DK (1) DK1069890T3 (es)
EE (1) EE200000595A (es)
ES (1) ES2267268T3 (es)
HU (1) HUP0102305A3 (es)
ID (1) ID29286A (es)
IL (1) IL138635A0 (es)
IS (1) IS5656A (es)
NO (1) NO329145B1 (es)
NZ (1) NZ507190A (es)
PL (1) PL344077A1 (es)
PT (1) PT1069890E (es)
RU (1) RU2208435C2 (es)
SE (1) SE9801287D0 (es)
SK (1) SK14112000A3 (es)
TR (1) TR200002960T2 (es)
TW (1) TW542724B (es)
WO (1) WO1999052507A1 (es)
ZA (1) ZA992549B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242112A4 (en) * 1999-12-21 2005-02-09 Rxkinetix Inc PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CN100478026C (zh) * 2001-09-28 2009-04-15 纽特休迪克斯公司 用于生物学组分的传递系统
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
KR20060015587A (ko) 2003-05-08 2006-02-17 넥타 쎄라퓨틱스 유케이 리미티드 미립물
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) * 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
WO2007133750A2 (en) * 2006-05-12 2007-11-22 The Board Of Trustees Of The Leland Stanford Junior University Encapsulated nanoparticles for drug delivery
FR2900845B1 (fr) 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (en) 2006-10-19 2008-04-23 Gerhard, Markus Novel method for treating H.pylori infections
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
DK1069890T3 (da) 2006-08-28
SK14112000A3 (sk) 2001-07-10
JP2002511400A (ja) 2002-04-16
SE9801287D0 (sv) 1998-04-14
HUP0102305A2 (hu) 2001-12-28
NO20005150L (no) 2000-12-08
NO329145B1 (no) 2010-08-30
AU4066399A (en) 1999-11-01
ES2267268T3 (es) 2007-03-01
ZA992549B (en) 1999-10-14
HUP0102305A3 (en) 2003-04-28
CN1201728C (zh) 2005-05-18
PL344077A1 (en) 2001-09-24
IS5656A (is) 2000-10-11
CA2327522A1 (en) 1999-10-21
NZ507190A (en) 2002-02-01
KR100600691B1 (ko) 2006-07-19
DE69931904T2 (de) 2006-12-21
IL138635A0 (en) 2001-10-31
TW542724B (en) 2003-07-21
PT1069890E (pt) 2006-09-29
NO20005150D0 (no) 2000-10-13
AU744874B2 (en) 2002-03-07
EE200000595A (et) 2002-04-15
ID29286A (id) 2001-08-16
CZ20003784A3 (cs) 2001-08-15
EP1069890B1 (en) 2006-06-14
CA2327522C (en) 2008-03-25
ATE329580T1 (de) 2006-07-15
EP1069890A1 (en) 2001-01-24
CN1309555A (zh) 2001-08-22
KR20010042660A (ko) 2001-05-25
WO1999052507A1 (en) 1999-10-21
CY1105154T1 (el) 2010-03-03
TR200002960T2 (tr) 2000-12-21
RU2208435C2 (ru) 2003-07-20
BR9909636A (pt) 2000-12-19
DE69931904D1 (de) 2006-07-27
US6372260B1 (en) 2002-04-16

Similar Documents

Publication Publication Date Title
AR019262A1 (es) Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso.
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
BR0114628A (pt) Membro de retenção em microprojeção para aplicador de impacto
BR9900844A (pt) Método para microencapsulação de uma substância sólida
BRPI0416038A (pt) gel baseado em tensoativo como um veìculo injetável de liberação sustentada de droga
BR0215052A (pt) Composições acaricidas e métodos
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
BRPI0212028B1 (pt) sistema terapêutico transdérmico (tts) e seu processo de produção
CL2007001889A1 (es) Uso de un inhibidor de proteina farnesil tansferasa (fpt) definido, que es una benzocicloheptapiridina, en combinacion con paclitaxel para preparar un medicamento util para tratar una enfermedad proliferativa en un paciente
NO20031249L (no) Emulsjonspreparater samt konsentrater derav
BR0012152A (pt) Sistema de microrreservatórios na base de polissiloxanos e solventes ambifìlicos
ATE501710T1 (de) Somatostatin-analog-formulierungen
AR032415A1 (es) Producto para el modelado del cabello, de doble fase, que brinda beneficios de modelado y acondicionamiento
PL2088186T3 (pl) Wieloskładnikowy układ rzadki do gęstego
PA8584101A1 (es) Composicion antihelmintica e inyectable mejoradora de crecimiento
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
ES2176961T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
BR0211922A (pt) Método para secagem de artigos de tecido contendo fluido lipofìlico, sistema de secagem dos referidos artigos, bem como artigo de tecido assim obtido
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
BR9809226A (pt) Processo de epoxidação usando-se um composto de peroxotungstato estabilizado com fosfato como catalisador
BR0014577A (pt) Método e sistema para refrigerar e efetuar mudança no estado de uma mistura lìquida
BRPI0414524A (pt) misturas de agente tenso-ativo/solvente
AR057194A1 (es) Una composicion que comprende sistemas odorantes estables
BR9914964A (pt) Composição lìquida aquosa
BR0111669A (pt) Novos compostos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal